tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
DRMA
Dermata Therapeutics
RESEARCH TOOLSreports
Want to see DRMA full AI Analyst Report?

Dermata Therapeutics (DRMA) Income Statement

150 Followers

Dermata Therapeutics Income Statement

Last quarter (Q1 2026), Dermata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Dermata Therapeutics's net income was $-1.85M. See Dermata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 7.77M$ 12.51M$ 8.04M$ 9.67M$ 7.86M
Depreciation and Amortization
$ 0.00$ 0.00$ 8.04M$ 0.00$ 0.00
EBITDA
$ -7.77M$ -12.29M$ 247.22K$ -9.61M$ -7.86M
Operating Income
$ -7.77M$ -12.51M$ -8.04M$ -9.67M$ -7.86M
Other Income/Expenses
$ 215.04K$ 225.78K$ 247.22K$ 63.57K$ -45.61K
Pretax Income
$ -7.56M$ -12.29M$ -7.79M$ -9.61M$ -7.90M
Net Income
$ -7.56M$ -12.29M$ -7.79M$ -9.61M$ -7.90M
Per Share Metrics
Basic EPS
$ -8.16$ -80.32$ -401.80$ -139.20$ -152.70
Diluted EPS
$ -8.16$ -80.32$ -399.81$ -139.20$ -152.70
Weighted Average Shares Outstanding
 926.19K 153.00K 19.40K 69.07K 52.05K
Weighted Average Shares Outstanding (Diluted)
 926.19K 153.00K 19.50K 69.07K 52.05K
Currency in USD

Dermata Therapeutics Earnings and Revenue History